Stardots AB

Stardots AB is a Swedish deep-tech company based in Uppsala that develops medical device software (SaMD), algorithms and digital biomarkers for neurology and psychiatry. The company positions itself at the intersection of engineering, mathematics and life science, aiming to bring objective measurement to conditions such as Parkinson's disease, autism and ADHD that traditionally lack biomarkers. Its stated mission is to support clinical decisions with fast, detailed and objective symptom quantification, to strengthen clinical consistency through standardized assessments, and to optimize individualized treatment using algorithms and digital twins. Stardots describes itself as a deep-tech company that brings together engineers and mathematicians with scientists and life-science developers. Its leadership combines startup founders and seasoned subject-matter experts, and the company emphasizes an evidence-based, human-centric and results-focused approach. The management team includes CEO and co-founder Daniel Petrini, CTO Jakob Sandström, COO Martin Nilsson, Product Manager Lina Uggla, QA/RA Manager Malin Kylberg, and Business Developer USA Stefan Folkesson. Scientific leadership includes Alexander Medvedev and Pär Nyström, with Hanno Lindroth serving as Chairman of the board and co-founder. The company's product pipeline includes ANLIVA, which is being evaluated in a new US clinical study involving deep brain stimulation. Stardots has announced collaborations with researchers from Harvard Medical School and with Karolinska Institutet, and a Parkinson clinical trial has started in the USA. The company presents itself as a proud partner of several organizations in the healthcare ecosystem. Stardots operates from Uppsala, Sweden, and is expanding its presence in the United States through clinical studies and business development. It is a private company and a partner in the broader digital health and medical device software landscape.

Stardots AB is a Swedish deep-tech company based in Uppsala. It was founded by a group that includes Daniel Petrini, Alexander Medvedev and Hanno Lindroth, combining backgrounds in engineering, mathematics and life science. The company's stated purpose is to improve outcomes in the treatment of nervous system patients by transforming scientific discoveries into optimized treatments. From its early days, Stardots has focused on developing medical device software (SaMD), algorithms and digital biomarkers for neurology and psychiatry. The company identified a gap: most neurological and psychological conditions, including Parkinson's disease, autism and ADHD, lack traditional biomarkers, while an ageing population is expected to increase Parkinson's cases and diagnoses of autism and ADHD continue to rise. Stardots set out to support clinical decisions with objective measurements, standardized assessments and personalized care. The company has built a product pipeline that includes ANLIVA, which is being evaluated in a new US clinical study involving deep brain stimulation. Stardots has also announced collaborations with researchers from Harvard Medical School and with Karolinska Institutet, and a Parkinson clinical trial has started in the USA. These activities reflect the company's strategy of combining clinical research with software development. Stardots operates from Uppsala, Sweden, and has expanded its reach to the United States through clinical studies and the appointment of a Business Developer USA. The company describes itself as a proud partner of several organizations in the healthcare ecosystem. It remains a private company, with a leadership team that mixes startup founders and seasoned subject-matter experts.

• Stardots AB founded in Uppsala, Sweden, by Daniel Petrini, Alexander Medvedev and Hanno Lindroth

• New collaboration announced with researchers from Harvard Medical School

• ANLIVA evaluated in a new US clinical study involving deep brain stimulation

• New Karolinska Institutet collaboration announced

• Parkinson clinical trial started in USA

Deep-tech medical software for objective measurement in neurology and psychiatry, combining engineering, mathematics and life science.

• ANLIVA

  Product in Stardots' pipeline, evaluated in a new US clinical study involving deep brain stimulation.

• Medical device software (SaMD)

  Software intended for medical purposes, supporting clinical decisions with objective measurements.

• Digital biomarkers

  Objective, quantifiable physiological and behavioral data collected and measured via digital devices.

• Clinical decision support

  Algorithms and tools that assist clinicians in making diagnostic and treatment decisions.

1. 1Home - Stardotsstardots.se
2. 2Stardots – compassionate innovation.stardots.se
3. 3Stardots AB (Sweden) - Wikidatawikidata.org